BioNTech SE (BNTX) Depreciation & Amortization (CF) (2018 - 2021)

BioNTech SE has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $15.7 million in Q1 2021.

• Quarterly Depreciation & Amortization (CF) rose 65.17% year-over-year to $15.7 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $15.7 million (up 65.17% YoY) and the FY2020 annual result came in at $44236.9, up 16.53% from the prior year.
• Depreciation & Amortization (CF) climbed to $15.7 million in Q1 2021 per BNTX's latest filing, from $9.5 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $15.7 million in Q1 2021 and troughed at -$26.6 million in Q4 2019.
• A 4-year average of -$4.3 million and a median of -$3.1 million in 2018 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2019 and 2021: Depreciation & Amortization (CF) sank 69.8% in 2019, then surged 65.17% in 2021.
• Over 4 years, Depreciation & Amortization (CF) stood at -$15.7 million in 2018, then tumbled by 69.8% to -$26.6 million in 2019, then surged by 135.66% to $9.5 million in 2020, then soared by 65.17% to $15.7 million in 2021.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $15.7 million, $9.5 million, and -$26.6 million for Q1 2021, Q1 2020, and Q4 2019 respectively.